author-photo

Mario A. Eisenberger

Johns Hopkins University
Johns Hopkins University School of Medicine
University of Maryland, Baltimore

525

Papers

32446

Citations

Citation Trend

Filter By

Papers (525) Sort By

Journal Conference Others

TRANSFORMER: A Randomized Phase II Study Comparing Bipolar Androgen Therapy Versus Enzalutamide in Asymptomatic Men With Castration-Resistant Metastatic Prostate Cancer.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (10)
Timing of Androgen Deprivation Treatment for Men with Biochemical Recurrent Prostate Cancer in the Context of Novel Therapies.

2021 The Journal of Urology
Show All
- Source
- Cite
- Save
Citations (1)
Post Hoc Health-Related Quality of Life Analysis According to Response Among Patients with Prostate Cancer in the PROSELICA and FIRSTANA Studies.

2021 Oncologist
Show All
- Source
- Cite
- Save
Citations (0)
Clinical study of VERU-111, an oral cytoskeletal disruptor, in metastatic castration-resistant prostate cancer (mCRPC) who failed an androgen receptor targeting agent.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Combined longitudinal clinical and autopsy phenomic assessment in lethal metastatic prostate cancer: recommendations for advancing precision medicine

2021
Show All
- Source
- Cite
- Save
Citations (1)
Clinical study of VERU-111, an oral cytoskeletal disruptor in men with metastatic Castration Resistant Prostate Cancer (mCRPC) who failed an androgen receptor targeting agent

2021 European Urology
Show All
- Source
- Cite
- Save
Citations (0)
Phase I study of CCW702, a bispecific small molecule-antibody conjugate targeting PSMA and CD3 in patients with metastatic castration-resistant prostate cancer (mCRPC).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Bipolar androgen therapy sensitizes castration-resistant prostate cancer to subsequent androgen receptor ablative therapy.

2021 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (3)
Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate-Specific Membrane Antigen (PSMA)-Targeted 18F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or Enzalutamide.

2021 The Journal of Nuclear Medicine
Show All
- Source
- Cite
- Save
Citations (4)
Elucidating Prostate Cancer Behaviour During Treatment via Low-pass Whole-genome Sequencing of Circulating Tumour DNA

2021 European Urology
Show All
- Source
- Cite
- Save
Citations (1)